AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATEDINVESTOR RIGHTS AGREEMENT
Exhibit 4.4
AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
THIS AMENDMENT NO. 1 (the Amendment) to the THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the IRA), dated December 27, 2005, by and among Quark Biotech, Inc., a California corporation (the Company), the Series A Investors, the Series B Investors, the Series C Investors, the Series D Investors, the Series E Investors, the Series F Investors, the Series G Investors, the Common Holders and the Founders (all collectively the Parties), is made effective as of February 12, 2007 by and among the Parties. All capitalized terms used but not defined herein shall have the meanings given to them in the IRA.
RECITALS
WHEREAS, the parties hereto have previously entered into the IRA; and
WHEREAS, in accordance with Section 8.2 of the IRA, the parties hereto wish to amend the IRA to reflect the agreements set forth herein.
NOW, THEREFORE, in consideration of the promises and of the mutual covenants contained herein, the Parties hereby agree to amend the IRA as follows:
AGREEMENT
1. Amendment to Section 2.5(a).
The following language contained in Section 2.5(a) of the IRA:
(z) the pre-offering market capitalization of the corporation is at least $200,000,000 (or ¥20,000,000,000 if the primary listing of shares in on a Japan exchange or over-the-counter market)
shall be amended to read as follows:
(z) the pre-offering market capitalization of the corporation is at least $125,000,000 (or ¥12,500,000,000 if the primary listing of shares in on a Japan exchange or over-the-counter market)
2. General
(a) Full Force and Effect. Except as expressly modified by this Amendment, all of the terms and conditions of the IRA shall remain in full force and effect.
(b) Counterparts. This Amendment may be executed simultaneously in two or more counterparts, each of which shall be considered an original, but all of which together shall constitute one and the same instrument.
(c) Governing Law. This Amendment shall be governed by and construed and interpreted in accordance with the laws of the State of California.
In Witness Whereof, the Parties hereto have executed this Amendment as of the day and year first set forth above.
| QUARK BIOTECH, INC. | ||
|
| ||
|
| ||
| /s/ Daniel Zurr |
| |
| Daniel Zurr, Ph.D. | ||
| Chief Executive Officer | ||
|
| ||
| Address: | 6501 Dumbarton Circle | |
| Fax: | (510) 402-4020 | |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| COMMON HOLDERS AND | |
|
| |
| /s/ David M. Fineman | |
| /s/ Ellen Gunn Fineman |
|
| David M. Fineman and Ellen Gunn Fineman, | |
|
| |
|
| |
| /s/ Ellen Gunn Fineman |
|
| Ellen Gunn Fineman, as Custodian for Chloe Rose | |
|
| |
|
| |
| /s/ Ellen Gunn Fineman |
|
| Ellen Gunn Fineman, as Custodian for Emma Hart | |
|
| |
|
| |
|
|
|
| John V. Roos | |
|
| |
|
| |
|
|
|
| Bonnee Rubinfeld | |
|
| |
|
| |
|
|
|
| Bonnee Rubinfeld and | |
|
| |
|
| |
|
|
|
| Loretta Rubinfeld, JTWROS | |
|
| |
|
| |
| /s/ J. Gregory Swendsen |
|
| J. Gregory Swendsen, |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Common Holders and Founders contd] | |
|
| |
|
|
|
|
|
|
| Susan H. Bell, | |
|
| |
|
| |
| /s/ Daniel Zurr |
|
| Daniel Zurr | |
|
| |
|
| |
| /s/ Daniel Zurr |
|
| Daniel Zurr, |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES A INVESTORS | |
|
| |
|
| |
| /s/ Donald Campbell |
|
| Donald T. Campbell, IRA FBO Donald T. | |
|
| |
|
| |
| /s/ David L. Austin |
|
| David L. Austin, MLPF&S | |
|
| |
|
| |
| /s/ Frances M. Austin |
|
| Frances M. Austin, MLPF&S Custodian | |
|
| |
|
| |
|
|
|
| Deborah R. Bernstein and | |
|
| |
|
| |
|
|
|
| Harvey S. Hecht, as Community Property | |
|
| |
|
| |
|
|
|
| Harvey S. Hecht | |
|
| |
|
| |
|
|
|
| Robert Brockman, | |
|
| |
|
| |
|
|
|
| First Trust Corporation TTEE FBO |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | |
|
| |
|
| |
| /s/ Patricia Berns |
|
| Patricia Berns | |
|
| |
|
| |
|
|
|
| Deborah R. Bernstein and Harvey S. Hecht, | |
|
| |
|
| |
|
|
|
| Robert Bruchnan and | |
|
| |
|
| |
|
|
|
| Mari Brockman, as Community Property | |
|
| |
|
| |
|
|
|
| Robert Bruckman, | |
|
| |
|
| |
|
|
|
| Robert Bruckman, TTEE | |
|
| |
|
| |
|
|
|
| Jerome C. Dougherty, | |
|
| |
|
| |
|
|
|
| Chrism Pardee Erdman |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | ||
|
| ||
|
| ||
|
|
| |
| Lois Pat Lee Gintjee, | ||
|
| ||
|
| ||
| /s/ David Fineman |
| |
| David Fineman, TTEE, | ||
|
| ||
|
| ||
| /s/ Joyce Hawkins |
| |
| Joyce Hawkins, TTEE, | ||
|
| ||
|
| ||
|
|
| |
| Jeffrey A. Hawkins | ||
|
| ||
|
| ||
|
|
| |
| Jonathan D. Hawkins | ||
|
| ||
|
| ||
| /s/ Roger W. Hedin, M.D. |
| |
| Roger W. Hedin, M.D. and | ||
|
| ||
|
| ||
| /s/ Mary A. Hedin |
| |
| Mary A. Hedin, as Community Property | ||
|
| ||
|
| ||
|
|
| |
| Bonnie J. Lawless | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | |
|
| |
|
| |
| /s/ Kathleen Lewis, M.D. |
|
| Kathleen Lewis, M.D. and | |
|
| |
|
| |
| /s/ Julien Hoffman |
|
| Julien Hoffman, as Community Property | |
|
| |
|
| |
| /s/ Kathleen Lewis, M.D. |
|
| San Francisco Neonatology Medical Group | |
|
| |
|
| |
|
|
|
| W. Scott Newhall | |
|
| |
|
| |
|
|
|
| Mark I. Peterson, TTEE, | |
|
| |
|
| |
| /s/ Polly Sue Ogden |
|
| Polly Sue Ogden, TTEE, | |
|
| |
|
| |
|
|
|
| Donald H. Oppenheim | |
|
| |
|
| |
| /s/ Peter Oppenheim |
|
| Peter Oppenheim, TTEE, |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | ||
|
| ||
| /s/ Sylvia Oppenheim |
| |
| Sylvia Oppenheim, TTEE, | ||
|
| ||
|
| ||
|
|
| |
| Joseph D. Sabella, TTEE, | ||
|
| ||
|
| ||
|
|
| |
| Iris Sabella, | ||
|
| ||
|
| ||
|
|
| |
| Jack Sender and | ||
|
| ||
|
| ||
|
|
| |
| Merideth Sender, as Community Property | ||
|
| ||
|
| ||
| /s/ Alfred D. Oppenheim |
| |
| Alfred D. Oppenheim, TTEE, | ||
|
| ||
|
| ||
| /s/ Terri A. Slagle |
| |
| Terri A. Slagle, TTEE, | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | |
|
| |
|
| |
| /s/ Terri A. Slagle |
|
| Terri A. Slagle, | |
|
| |
|
| |
| /s/ Steven Goldman |
|
| Steven Goldman, | |
|
| |
|
| |
| /s/ Gerald L. Vercesi |
|
| Gerald L. Vercesi, TTEE, | |
|
| |
|
| |
| /s/ Donna E. Vercesi |
|
| Donna E. Vercesi, TTEE, | |
|
| |
|
| |
|
|
|
| James L. Warren and | |
|
| |
|
| |
|
|
|
| Cassandra H. Warren, as Community Property | |
|
| |
|
| |
|
|
|
| Mark Wexman, | |
|
| |
|
| |
|
|
|
| Mark Wexman, M.D. and |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series A Investors contd] | ||||
|
| ||||
|
| ||||
|
|
| |||
| Karen Wexman, M.D., as Community Property | ||||
|
| ||||
|
|
| |||
| WS INVESTMENT COMPANY 94A | ||||
|
| ||||
|
| ||||
| By: | /s/ Illegible |
| ||
| Title: |
|
| ||
|
|
| |||
|
|
| |||
|
|
| |||
| Howard B. Zack and | ||||
|
| ||||
|
| ||||
|
|
| |||
| Diane C. Zack, as Community Property | ||||
|
| ||||
|
| ||||
| /s/ John Ziegler |
| |||
| John Ziegler | ||||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES B INVESTORS | |
|
| |
|
| |
|
|
|
| Delaware Charter Guarantee & Trust Co., fbo | |
|
| |
|
| |
|
|
|
| Mark Wexman, MD: and | |
|
| |
|
| |
|
|
|
| Karen Wexman, M.D., as Community Property | |
|
| |
|
| |
|
|
|
| Diane C. Zack and | |
|
| |
|
| |
|
|
|
| Howard B. Zack, as Community Property |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES B PURCHASERS |
|
|
|
|
| TAKO VENTURES, LLC |
| By: | Cephalopod Corporation, Member | |
|
|
| |
|
| By: Philip B. Simon, President | |
|
|
| |
| /s/ Philip B. Simon |
| |
|
| |
| /s/ Donald T. Campbell |
|
| Donald T. Campbell, IRA FBO Donald T. | |
|
| |
|
| |
|
|
|
| Christian Pardee Erdman | |
|
| |
|
| |
| /s/ Steven Goldman |
|
| Steven Goldman, M.D. | |
|
| |
|
| |
| /s/ Peter Oppenheim |
|
| Peter and Sylvia Oppenheim, Trustees | |
|
| |
|
| |
| /s/ Sylvia Oppenheim |
|
| Peter and Sylvia Oppenheim, Trustees |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES C INVESTORS |
|
|
|
|
| TAKO VENTURES, LLC |
| By: | Cephalopod Corporation, Member |
|
|
|
|
| By: Philip B. Simon, President |
|
|
|
| /s/ Philip B. Simon |
| |
|
| ||
|
| ||
|
|
| |
| Jeffrey A. Hawkins | ||
|
| ||
|
| ||
|
|
| |
| Peter Oppenheim and | ||
|
| ||
|
| ||
|
|
| |
| Sylvia Oppenheim, TTEES of the Oppenheim | ||
|
| ||
|
| ||
|
|
| |
| Diane C. Zack and | ||
|
| ||
|
| ||
|
|
| |
| Howard B. Zack, as Community Property | ||
|
| ||
|
| ||
|
|
| |
| Joseph Rubinfeld | ||
|
| ||
|
| ||
|
|
| |
| John V. Roos | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series C Investors contd] |
|
|
|
|
|
|
| WS INVESTMENT COMPANY 96B |
|
|
| By: | /s/ Illegible |
| |
| Title: |
|
| |
|
| |
| SUPERGEN, INC., | |
|
| |
|
| |
|
|
|
| Joseph Rubinfeld, President |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES D INVESTOR | ||
|
| ||
|
| ||
| TAKO VENTURES, LLC | ||
|
| ||
| By: | Cephalopod Corporation, Member | |
|
|
| |
|
| By: Philip B. Simon, President | |
|
|
| |
| /s/ Philip B. Simon |
| |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES E INVESTORS |
|
|
|
|
| TAKO VENTURES, LLC |
| By: | Cephalopod Corporation, Member |
|
|
|
|
| By: Philip B. Simon, President |
| /s/ Philip B. Simon |
| |
|
| ||
|
| ||
|
|
| |
| Robert M. Lawless, TTEE, | ||
|
| ||
|
| ||
| /s/ Gerald L. Vercesi |
| |
| Gerald L. Vercesi, TTEE, | ||
|
| ||
|
| ||
| /s/ Donna E. Vercesi |
| |
| Donna E. Vercesi, TTEE, | ||
|
| ||
|
| ||
|
|
| |
| James L. Warren and | ||
|
| ||
|
| ||
|
|
| |
| Cassandra H. Warren, as Community Property | ||
|
| ||
|
| ||
|
|
| |
| Delaware Charter Guarantee & Trust Co., | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| [Series E Investors contd] | |
|
| |
|
| |
|
|
|
| CNA TRUST, TTEE FBO Mark Wexman, |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES F INVESTORS | |||
|
| |||
|
| |||
| TAISHO PHARMACEUTICAL CO., LTD. | |||
|
| |||
|
| |||
| /s/ Akira Uehara |
| ||
| Akira Uehara | |||
|
| |||
|
| |||
| ASTELLAS PHARMA INC. | |||
|
| |||
|
| |||
| /s/ Hirofaini Onosaka |
| ||
| Hirofaini Onosaka | |||
|
| |||
|
| |||
| MITSUBISHI PHARMA CORPORATION | |||
|
| |||
|
| |||
| /s/ Takeshi Komine |
| ||
| Name: | Takeshi Komine |
| |
| Title: | President |
| |
|
| |||
|
| |||
| SANKYO CO., LTD. | |||
|
| |||
|
| |||
| Name: |
|
| |
| Title: |
|
| |
|
|
|
| |
| /s/ Doug H. Harlan |
| ||
| Doug H. Harlan | |||
|
|
|
| |
| /s/ Hugh P. Harlan |
| ||
| Hugh P. Harlan | |||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| SERIES G INVESTORS |
|
|
|
|
| TRANS-SCIENCE GLOBAL BIO- |
| By: | SBI Asset Management Co., Ltd. | |
|
| ||
|
| ||
| /s/ Kazuyuki Matsui |
| |
| Name: Kazuyuki Matsui | ||
| Title: President | ||
|
| ||
|
| ||
| TS-US NO.1 INVESTMENT | ||
| By: | Trans-Science, Inc. |
|
| ||
| /s/ Kiyoshi Inoue |
| |
| Name: Kiyoshi Inoue | ||
| Title: CEO & President | ||
|
| ||
|
| ||
| ASUKA DBJ INVESTMENT LPS | ||
|
| ||
| By: | Asuka DBJ Partners Co., Ltd. | |
|
| ||
|
| ||
| /s/ Toru Mio |
| |
| Name: Toru Mio | ||
| Title: Representative Director | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
| MUFG VENTURE CAPITAL I, LIMITED PARTNERSHIP | |
|
| |
| By: | The Mitsubishi UFJ Capital Company |
|
| ||
| /s/ Kazuhiko Tokita |
| |
| Name: Kazuhiko Tokita | ||
| Title: President | ||
|
| ||
|
| ||
| ORIX FUND NO. 9 | ||
|
| ||
| By: | Orix Capital Corporation | |
|
| ||
|
| ||
| /s/ Akira Hirose |
| |
| Name: Akira Hirose | ||
| Title: President | ||
|
| ||
|
| ||
| CONCORDIA INVESTMENT, L.P. | ||
|
| ||
| /s/ Hirotoshi Komoda |
| |
| Name: Hirotoshi Komoda | ||
| Title: | CEO& President, Birdhill, | |
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]
|
| ||
| TRANS-SCIENCE NO.3 INVESTMENT LIMITED PARTNERSHIP | ||
|
| ||
| By: | Trans-Science, Inc. | |
|
| ||
|
| ||
| /s/ Kiyoshi Inoue |
| |
| Name: Kiyoshi Inoue | ||
| Title: CEO & President | ||
|
| ||
|
| ||
| TOKIO MARINE & NICHIDO FIRE | ||
|
| ||
| New Financial Markets Dep | ||
|
| ||
|
| ||
| /s/ Takashi Yoshikawa |
| |
| Name: Takashi Yoshikawa | ||
| Title: General Manager | ||
|
| ||
| ZENSHIN CAPITAL FUND 1F | ||
| By: | Zenshin Capital Partners, LLC | |
|
| ||
|
| ||
| /s/ Takeshi Mori |
| |
| Name: Takeshi Mori | ||
| Title: Managing Member | ||
[SIGNATURE PAGE TO AMENDMENT NO. 1 TO THIRD AMENDED
AND RESTATED INVESTORS RIGHTS AGREEMENT]